Oxtoby Andrew
Insider CIK 1765473 · KDNY Chief Commercial Officer · AIMT Chief Commercial Officer · KLRS See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-20 | 222,000 | — | $0 | 222,000 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2025-04-10 | 2025-04-11 | 287,000 | — | $0 | 287,000 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2025-03-18 | 2025-03-18 | 476,611 | — | $0 | 476,611 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 160,000 | $18.18 | $2.91M | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 40,000 | — | $0 | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2023-02-28 | 2023-03-02 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2023-02-28 | 2023-03-02 | 160,000 | — | $0 | 160,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 150,000 | $12.56 | $1.88M | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 67,500 | $10.69 | $721.6K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer | 2020-10-13 | 2020-10-14 | 20,250 | $34.50 | $698.6K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | U Tender | 2020-10-10 | 2020-10-14 | 6,345 | $34.50 | $218.9K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | F Tax w/h | 2020-09-15 | 2020-09-16 | 840 | $34.25 | $28.8K | 26,595 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2020-05-10 | 2020-05-12 | 2,420 | — | $0 | 27,435 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2020-03-13 | 2020-03-17 | 3,000 | $14.76 | $44.3K | 25,015 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2020-02-28 | 2020-03-03 | 67,500 | — | $0 | 67,500 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2020-02-28 | 2020-03-04 | 67,500 | — | $0 | 67,500 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2020-02-28 | 2020-03-03 | 11,250 | — | $0 | 23,250 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2020-02-28 | 2020-03-04 | 11,250 | — | $0 | 22,015 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | F Tax w/h | 2020-01-22 | 2020-03-04 | 1,235 | $33.23 | $41.0K | 10,765 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2019-01-22 | 2019-01-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2019-01-22 | 2019-01-24 | 12,000 | — | $0 | 12,000 | SEC↗ |